Prostamax: Dosage, Benefits & Side Effects

By Peptide Assistant Editorial Team · · · 8 sources cited

Overview

Prostamax is a synthetic bioregulator tetrapeptide (Lys-Glu-Asp-Pro) developed by the Khavinson laboratory that targets prostate tissue. It is designed to normalize prostate gland function, reduce inflammation, and support healthy cell differentiation in aging prostate tissue. As a bioregulator, it is proposed to work through epigenetic modulation of gene expression; the published experiments on this used blood lymphocytes from elderly people, not prostatic cells.

Mechanism of Action

Prostamax is a short peptide proposed to enter cells and interact with DNA to modulate gene expression. In cultured blood lymphocytes from people aged 75–88 it loosened condensed chromatin (heterochromatin) and activated ribosomal genes, and in test-tube experiments it changed the melting temperature of DNA. In tissue culture it stimulated the growth of prostate explants from young and old rats. Effects on PSA, prostatic enzymes and growth factors, inflammatory cytokines (IL-6, TNF-α), 5-alpha-reductase or androgen receptor expression have not been published.

Prostamax Benefits: What the Research Shows

  • A tissue-culture study found that Prostamax stimulated the growth of prostate explants from young (3-week) and aged (18-month) rats; no study in living aged animals was found
  • Studies in cultured blood lymphocytes from people aged 75–88 showed that Prostamax loosened condensed chromatin and activated ribosomal genes; no study of inflammatory markers in prostate tissue cultures was found
  • Russian clinical reports of improved symptoms in chronic prostatitis (for example 307 patients treated by injection) concern Prostatilen, a polypeptide extract of animal prostate, not the synthetic tetrapeptide Prostamax; no clinical study of Prostamax or of its effect on PSA was found

Prostamax Dosage

  • Oral: 10–20 mg daily in capsule form for 10–30 days
  • Repeat cycles every 3–6 months
  • For active prostate support: 20 mg daily for 20–30 days
  • For maintenance: 10 mg daily for 10–15 days every 4–6 months
  • Can be combined with other prostate-supportive interventions
Peptide calculator: get your dose in syringe units →

Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.

Prostamax Side Effects & Safety

Known Side Effects

  • No published human study of Prostamax exists, so adverse effects have not been assessed
  • Mild GI discomfort — infrequently reported with oral dosing
  • No published clinical safety data
  • Theoretical interaction with hormonal prostate therapies

Safety Profile

Prostamax has no published human safety data. No adverse events appear in the published studies, but those are test-tube and cell-culture experiments. No human clinical trial of Prostamax was found; the clinical reports from this research group concern Prostatilen, a different product made from animal prostate extract. Men with diagnosed prostate cancer should consult their oncologist before using any prostate-targeted compound. Prostamax should not be used as a substitute for established medical treatment for BPH or prostate cancer.

What to Expect

Days 1–10: No immediate subjective effects expected. Epigenetic modulation of prostate gene expression begins at the cellular level. Days 10–30: Some users report improved urinary symptoms (reduced frequency, improved flow) if BPH-related symptoms were present. No published study has measured PSA levels after Prostamax. Post-cycle: Suppliers say benefits persist for weeks to months and build with repeated cycles every 3–6 months; neither has been studied.

Common Stacks

Storage & Handling

Store Prostamax capsules at room temperature (15–25°C) in a dry place away from direct sunlight. Shelf life is typically 2–3 years for encapsulated bioregulators. No refrigeration required for oral form.

Pricing & Available Variants

$60price range
20mg

Prices sourced from peptides.gg marketplace. Prices may vary.

References

  1. Khavinson VKh, Lezhava TA, Malinin VV. Effects of short peptides on lymphocyte chromatin in senile subjects. Bull Exp Biol Med. 2004.
  2. Dzhokhadze TA, Buadze TZh, Gaĭozishvili MN, et al. Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro). Georgian Med News. 2012.
  3. Meskhi T, Khachidze D, Barbakadze Sh, et al. The influence of the peptide bioregulator prostamax on heterochromatin of human lymphocytes in situ. Biofizika. 2004.
  4. Zakutskiĭ AN, Chalisova NI, Ryzhak GA, et al. The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats. Adv Gerontol. 2006.
  5. Solovyev AY, Tarnovskaya SI, Chernova IA, et al. The interaction of amino acids, peptides, and proteins with DNA. Int J Biol Macromol. 2015.
  6. Khavinson V, Linkova N, Kozhevnikova E, et al. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. Int J Mol Sci. 2022.
  7. Tkachuk VN, Gorbachev AG, Khavinson VKh. The use of prostatilen in treating patients with chronic prostatitis. Urol Nefrol (Mosk). 1991.
  8. Khavinson VKh, Kuznik BI, Ryzhak GA. Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results. Adv Gerontol. 2013.

Related Peptides

Track Prostamax in Your Protocol

Log your Prostamax doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.

Start Tracking Free